APPLICATIONS PUBLISHED 6 NOVEMBER 2002
Published: 1-May-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492
Pharmaceutical compsns for pulmonary delivery
King's College London 1235908*
Pharmaceutical formulations comprising labdanes for the treatment of tumours or leukaemias
PN Gerolymatos 1253909*
Combined diffusion/osmotic pumping drug delivery system
Osmotica 1253910*
Method for loading a red blood cell with an agent
Gendel 1253911*
Patch for local and transdermal administration of active ingredients containing anionic or electron-attracting groups
FT Holdings 1253913*
Use of gangliosides and other substances for modulating sphingolipid-cholesterol microdomains
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften 1253914*
Method for treating stress with a precursor of serotonin
Massachusetts Institute of Technology 1253915*
Method of treating vaginal dryness with nicotinic acetylcholine receptor agonists
Inspire Pharmaceuticals 1253916*
Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments
Gruenenthal 1253917*
Compsns including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
Cephalon 1253918*
Method and compsns for treating an inflammatory disease
SmithKline Beecham 1253919*
An essential constituent and method of use for maintaining hair coloration or reversing hair discoloration
The Regents of the University of California 1253920*
Treatment or prevention of prostate cancer with a COX-2 selective inhibiting drug
Merck & Co 1253921*
Statin-type bone growth stimulators
Osteoscreen 1253922*
Pharmaceutical compsns containing anti-beta 1 integrin compounds and uses
Biogen 1253923*
Nitrate salts of antimicrobial agents
Nicox 1253924*
Tetrahydropyrimidone inhibitors of fatty acid binding protein and methods
Bristol-Myers Squibb 1253925*
Compounds useful for the treatment or prevention of a disease mediated by the alpha-2B-adrenoreceptor
Oy Juvantia Pharma 1253926*
Method for preparing plant extracts, plant extracts obtained by said method, and use thereof
Institut des Substances Vegetales 1253927*
Novel haptotactic peptides
Hadasit Medical Research Services & Development 1253928*
Use of relaxin to treat diseases related to vasoconstriction
Connectics Corp; University of Pittsburgh of the Commonwealth System of Higher Education; The University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School 1253929*
Method and compsns for treating hepatocellular cancer
The Regents of the University of California 1253930*
Utilisation of protein kinase inhibitor alpha
Schering 1253931*
Botulinum toxin pharmaceutical compsns
Allergan 1253932*
Method for treating thyroid disorders
Allergan 1253933*
Methods for determining risk of developing cervical cancer
MUSC Foundation for Research Development 1253934*
Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischaemic diseases or stroke
D Collen Research Foundation; Flanders Interuniversity Institute for Biotechnology 1253935*
Microencapsulation and sustained release of biologically active agent
Alkermes Controlled Therapeutics 1253936*
Methods of therapy with thrombin derived peptides
The Board of Regents, The University of Texas Systems 1253937*
Immunisation of an individual against carcinoma and the preliminary stages thereof
Von Knebel Doeberitz, Magnus 1253938*
In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete ATP binding domain and is CD4+ T-cell-independent
Whitehead Institute for Biomedical Research; Massachusetts Institute of Technology 1253939*
Low dose haptenised tumour cell and tumour cell extract immunotherapy
Thomas Jefferson University 1253940*
Pre-transplant accommodated organs resistant to anti-donor immunity
Board of Regents of the University of Nebraska 1253941*
CD4-binding APC-activating molecules
Tanox 1253942*
Photodynamic therapy for treating conditions of the eye
Massachusetts Eye & Ear Infirmary 1253943*
Pharmaceutical compsn comprising a combination of metformin and another antidiabetic agent
Bristol-Myers Squibb 1253944*
ACE inhibitor-vasopressin antagonist combinations
Warner-Lambert 1253945*
Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
Alexion Pharmaceuticals 1253946*
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
The Regents of the University of California 1253947*
Gene therapy for treating ocular-related disorders
Genvec 1253948*
Propionic acid derivatives and their use in the treatment of diabetes and obesity
Novo Nordisk 1254101*
Alkylnylsubstituted propionic acid derivatives and their use against diabetes and obesity
Novo Nordisk 1254102*
Quaternary ammonium compounds and their use as anti-tussive agent
Cardiome Pharma 1254104*
Method for producing alkoxy malonic acid dinitriles
Lonza 1254105*
Calcilytic compounds
SmithKline Beecham; NPS Pharmaceuticals 1254106*
Benzoic acid esters, and liquid crystalline medium
Merck Patent 1254107*
Gamma-secretase-inhibitors
Merck Sharpe & Dohme 1254108*
